spironolactone has been researched along with Pituitary Neoplasms in 5 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prognosis of hypertension was evaluated pre-operatively in 40 patients with primary aldosteronism owing to adenoma by examining the severity of hypertension, family history of hypertension, age of the patients, duration of hypertension, plasma renin activity, plasma aldosterone concentration, and efficacy of spironolactone (100 mg per day for 10 days) on blood pressure." | 3.67 | Pre-operative evaluation of the prognosis of hypertension in primary aldosteronism owing to adenoma. ( Murai, M; Saito, I; Saruta, T; Suzuki, H; Takita, T; Tazaki, H, 1987) |
| "Only when the Cushing syndrome has been confirmed clinically and biochemically, should an imaging procedure be performed." | 1.31 | [Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease]. ( Füessl, HS, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emmert, AS | 1 |
| Hussein, AE | 1 |
| Slobodian, O | 1 |
| Krueger, B | 1 |
| Bhabhra, R | 1 |
| Hagen, MC | 1 |
| Pickle, S | 1 |
| Forbes, JA | 1 |
| Aron, DC | 1 |
| Tyrrell, JB | 1 |
| Fitzgerald, PA | 1 |
| Findling, JW | 1 |
| Forsham, PH | 1 |
| Füessl, HS | 1 |
| Andler, W | 1 |
| Roosen, K | 1 |
| Reinhardt, V | 1 |
| Saruta, T | 1 |
| Suzuki, H | 1 |
| Takita, T | 1 |
| Saito, I | 1 |
| Murai, M | 1 |
| Tazaki, H | 1 |
5 other studies available for spironolactone and Pituitary Neoplasms
| Article | Year |
|---|---|
Case Report of Transgender Patient with Gonadotropic Dysfunction Secondary to Craniopharyngioma: Toward Improving Understanding of Biopsychosocial Dynamics of Gender Identity in Neurosurgical Care.
Topics: Adult; Craniopharyngioma; Estradiol; Estrogens; Female; Humans; Male; Pituitary Neoplasms; Sex Reass | 2021 |
Cushing's syndrome: problems in diagnosis.
Topics: ACTH Syndrome, Ectopic; Adenoma; Adrenal Cortex Function Tests; Adrenocortical Hyperfunction; Adult; | 1981 |
[Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Algorithms; Cushing Sy | 2002 |
[Hypothalamic hyperosmolarity in childhood (author's transl)].
Topics: Astrocytoma; Brain Diseases; Brain Neoplasms; Child; Craniopharyngioma; Female; Histiocytosis, Lange | 1979 |
Pre-operative evaluation of the prognosis of hypertension in primary aldosteronism owing to adenoma.
Topics: Adenoma; Adult; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Pituitary Neopl | 1987 |